AquaGen is a leading biotechnology company based in Norway, specializing in the development, production, and delivery of genetic material to the global seafood industry. With a history dating back to 1985, the company focuses on selective breeding of Atlantic salmon and rainbow trout, ensuring the preservation of refined genetic material. Their dedication to market-oriented research and development has solidified their position as a top provider of fertilized eggs for these species, with a keen focus on genetic traits related to health, animal welfare, growth, and quality. AquaGen collaborates with national and international research institutions, conducting independent and cooperative R&D projects to drive innovation and enhance existing breeding and health work. Their family-based selective breeding approach has positioned them as a crucial national resource for research on Norwegian farmed salmon, contributing significantly to the sustainability and profitability of the aquaculture industry. Their slogan, "We develop, produce and deliver genetic start material (eggs) to the global aquaculture industry," encapsulates their core mission. With a vision to be the independent and leading provider of innovative genetic and biological products to the global aquaculture industry, AquaGen remains at the forefront of sustainable aquaculture practices with their pioneering genetic solutions.
There is no investment information